Long term clinical course of Tourette syndrome

Brain and Development

Volumn 34, Issue 8, 2012, Pages 667-673

  Rizzo, Renata ^a   Gulisano, Mariangela ^a   Calì, Paola Valeria ^a   Curatolo, Paolo ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

ADHD; Clinical phenotype; Long term clinical course; OCD; Tourette syndrome

Indexed keywords

NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOMUTILATION; COURSE EVALUATION; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PHENOTYPE; QUALITY OF LIFE; RAGE; RETROSPECTIVE STUDY; TIC;

ADOLESCENT; ANXIETY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; DEPRESSION; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PHENOTYPE; QUALITY OF LIFE; RAGE; RETROSPECTIVE STUDIES; SELF-INJURIOUS BEHAVIOR; SEVERITY OF ILLNESS INDEX; TIME; TOURETTE SYNDROME;

EID: 84864755042     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.11.006     Document Type: Article

References (31)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM-IV-TR. 4th ed. Revised. Washington DC: American Psychiatric Association; 2002.
2. Robertson M.M. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res 2008, 65:461-472.
3. State M.W. The genetics of Tourette disorder. Curr Opin Genet Dev 2011, 21:302-309.
4. Robertson M.M. Gilles de la Tourette syndrome: an update on complexities of phenotype and treatment. Br J Hosp Med 2011, 72:100-107.
5. Cavanna A.E., Schrag A., Morley D., Orth M., Robertson M.M., Joyce E., et al. The Gilles de la Tourette syndrome Quality of Life (GTS-QOL): development and validation. Neurology 2008, 71:1410-1416.
6. Bloch M.H., Craiglow B.G., Landeros-Weisenberger A., Dombrowski P.A., Panza K.E., Peterson B.S., et al. Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder. Pediatrics 2009, 124:1085-1093.
7. Robertson M.M. Tourette syndrome, associated conditions and complexity of treatment. Brain 2000, 123:425-462.
8. Robertson M.M., Althoff R.R., Hafez A., Pauls D.L. Principal components analysis of a large cohort with Tourette syndrome. Br J Psychiatry 2008, 193:31-36.
9. Grados M., Mathews C.A. Clinical phenomenology and phenotype variability in Tourette syndrome. J Psychosom Res 2009, 67:491-496.
10. Cavanna AE, Critchley HD, Orth M, Stern JS, Young MB, Robertson MM. Dissecting the Gilles de la Tourette spectrum: a factor analytic study on 639 patients. J Neurol Neurosurg Psychiatry 2011 Mar 24 [Epub ahead of print].
11. Bloch M.H., Leckman J.F. Clinical course of Tourette syndrome. J Psychosom Res 2009, 67:497-501.
12. Leckman J.F. Phenomenology of tic and natural history of tic disorders. Brain Dev 2003, 25(Suppl. 1):S24-S28.
13. Haddad A.D., Umoh G., Bhatia V., Robertson M.M. Adults with Tourette's syndrome with and without attention deficit hyperactivity disorder. Acta Psychiatr Scand 2009, 120:299-307.
14. Bloch M., State M., Pittenger C. Recent advances in Tourette syndrome. Curr Opin Neurol 2011, 24:119-125.
15. Orth M., Rothwell J.C. Motor cortex excitability and comorbidity in Gilles de la Tourette syndrome. J Neurol Neurosurg Psychiatry 2009, 80:29-34.
16. Miller A.M., Bansal R., Hao X., Sanchez-Pena J.P., Sobel L.J., Liu J., et al. Enlargement of thalamic nuclei in Tourette syndrome. Arch Gen Psychiatry 2010, 67:955-964.
17. Debes N.M., Hansen A., Skov L., Larsson H. A functional magnetic resonance imaging study of a large clinical cohort of children with Tourette syndrome. J Child Neurol 2011, 26:560-569.
18. Plessen K.J., Bansal R., Peterson B.S. Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res 2009, 67:559-573.
19. Fahim C., Yoon U., Das S., Lyttelton O., Chen J., Arnaoutelis R., et al. Somatosensory-motor bodily representation cortical thinning in Tourette: effects of tic severity, age and gender. Cortex 2010, 46:750-760.
20. Worbe Y., Gerardin E., Hartmann A., Valabrégue R., Chupin M., Tremblay L., et al. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome. Brain 2010, 133:3649-3660.
21. Draganski B., Martino D., Cavanna A.E., Hutton C., Orth M., Robertson M.M., et al. Multispectral brain morphometry in Tourette syndrome persisting into adulthood. Brain 2010, 133:3661-3675.
22. Neuner I., Kupriyanova Y., Stöcker T., Huang R., Posnansky O., Schneider F., et al. Microstructure assessment of grey matter nuclei in adult Tourette patients by diffusion tensor imaging. Neurosci Lett 2011, 487:22-26.
23. Gilbert D.L., Sallee F.R., Zhang J., Lipps T.D., Wassermann E.M. Transcranial magnetic stimulation-evoked cortical inhibition: a consistent marker of attention-deficit/hyperactivity disorder scores in Tourette syndrome. Biol Psychiatry 2005, 57:1597-1600.
24. Gilbert D.L. Motor cortex inhibitory function in Tourette syndrome, attention deficit disorder, and obsessive compulsive disorder: studies using transcranial magnetic stimulation. Adv Neurol 2006, 99:107-114.
25. Amat J.A., Bronen B.A., Saluja S., Sato S., Zhu H., Gorman D.A., et al. Increased number of subcortical hyperintensities on MRI in children and adolescents with Tourette's syndrome, obsessive-compulsive disorder, and attention deficit hyperactivity disorder. Am J Psychiatry 2006, 163:1106-1108.
26. Narr K.L., Woods R.P., Lin J., Kim J., Phillips O.R., Del'Homme M., et al. Widespread cortical thinning is a robust anatomical marker for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2009, 48:1014-1022.
27. Rizzo R., Curatolo P., Gulisano M., Virzì M., Arpino C., Robertson M.M. Disentangling the effects of Tourette syndrome and attention deficit hyperactivity disorder on cognitive and behavioral phenotypes. Brain Dev 2007, 29:413-420.
28. Bernard B.A., Stebbins G.T., Siegel S., Schultz T.M., Hays C., Morrissey M.J., et al. Determinants of quality of life in children with Gilles de la Tourette syndrome. Mov Disord 2009, 24:1070-1073.
29. Eddy C.M., Rizzo R., Gulisano M., Agodi A., Barchitta M., Calì P., et al. Quality of life in young people with Tourette syndrome: a controlled study. J Neurol 2011, 258:291-301.
30. Gorman D.A., Thompson N., Plessen K.J., Robertson M.M., Leckman J.F., Peterson B.S. Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study. Br J Psychiatry 2010, 197:36-44.
31. Eddy C.M., Cavanna A.E., Gulisano M., Agodi A., Barchitta M., Calì P., et al. Clinical correlates of quality of life in Tourette syndrome. Mov Disord 2011, 26(4):735-738. 10.1002/mds.23434.